Biohaven pharmaceutical holding company ltd.

Major-Pharmaceuticals

BHVN


215 Church Street
New Haven , CT 06510

Executive/
Director

Price

  • Last Close
  • $ 43.22
    $ +3.41 8.57 %
    Dec 9, 2024
  • 52-Week High/Low
  • $61.3 - $16.92
  • YTD
  • 1%

  • Trading Volume
  • 25,012
  • Market Cap Full
  • $ 3.5B
  • Shares Outstanding
  • 80.2M
    Nov 10, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - -4.5% 39.2% -5% -20.3% -14% -1.6% 27.7%
Q2 - - 42.9% 61.1% -15.3% 4% 42% 22.9% 75.1% -2.5%
Q3 - - 49.5% -8.9% -4% 8% 41.7% -95.7% 8.7% -
Q4 - - -24.1% -0.7% 30.6% 31.7% 0.2% 120.3% 77.7% -
J F M A M J J A S O N D
2024 3.9% 8% 13.8% -7.1% - - - - - - - -
2023 37.3% -19.8% -10.6% -4.3% 34% 36.5% -17% -7.8% 41.9% 2.1% 25.6% 28.4%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%37%48%56%61%-90%208%1%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - 1.74 -2.32 -1.41 -3.07 -4.27 - -1.03
Q2 - - 1.78 -1.01 -4.67 -3.08 -3.23 - -1.32
Q3 - - 1.19 -1.53 -2.04 -3.27 -2.63 - -1.50
Q4 - - 0.75 -1.29 -2.79 -3.64 -5.43 -1.82 -
A 0 0 5.5 -6.2 -10.9 -3 -5.4 -12.8 -3.85

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2022 2023
Mar - 68.2
Jun - 68.2
Sep - 68.3
Dec 68.2 80.2

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - 1.1 0.5 - -
Fixed Asset Turnover - 3.2 1.5 - -
Total Asset Turnover - 0.4 0.1 - -
Leverage
Debt Ratio - 0.7 0.4 - -
Debt – Equity Ratio - -0.8 -0.7 - -
Interest Coverage -284 -4.9 -5.3 -9.6 -14.1
Equity multiplier 0.1 -0.2 -0.1 -2.1 0.1